Pharmacodynamic optimization of ceftazidime against Pseudomonas aeruginosa: continuous infusion or intermittent administration?
Aguilar, L.; Giménez, M.J.; Martín, J.E.; Prieto, J.
Revista Espanola de Quimioterapia Publicacion Oficial de la Sociedad Espanola de Quimioterapia 18(1): 21-25
2005
ISSN/ISBN: 0214-3429 PMID: 15915228 Document Number: 590973
Document emailed within 1 workday
Related Documents
Pruekprasert, P.; Tunyapanit, W. 2005: In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa Southeast Asian Journal of Tropical Medicine and Public Health 36(5): 1239-1242Michel-Briand, Y.; Nicolas, T.; Godard, C.; Plesiat, P. 1992: Beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains Microbiologica 15(1): 65-69
Aguirrebengoa, L.; Montejo, M.; Urkijo, J.C.; Pérez-Escajadillo, J.; Hernández-Almaraz, J.L.; Aguirre, C. 1989: Usefulness of ceftazidime and imipenem for the treatment of Pseudomonas aeruginosa meningitis. Study of 3 patients Enfermedades Infecciosas y Microbiologia Clinica 7(4): 224-225
Drenjancević, D.; Vranes, J.; Bedenić, B.; Sakić-Zdravcević, K. 2007: In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains Collegium Antropologicum 31(1): 221-225
Sader; Cerbara; Luz; Hashimoto 1999: Evaluation of the Cephalosporins, Cefepime, Cefpirome and Ceftazidime, against Clinical Isolates of Imipenem-Resistant Pseudomonas aeruginosa Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(6): 231-237
Jaruratanasirikul, S.; Julamanee, J.; Sudsai, T.; Saengsuwan, P.; Jullangkoon, M.; Ingviya, N.; Jarumanokul, R. 2010: Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus Journal of the Medical Association of Thailand 93(2): 172-176
Conil, J.M.; Georges, B.; Fourcade, O.; Seguin, T.; Houin, G.; Saivin, S. 2007: Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration International Journal of Clinical Pharmacology and Therapeutics 45(3): 133-142
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Stakislavskiĭ, E.S.; Kolker, I.I. 1978: Immunological study of cellular components of Pseudomonas aeruginosa. IV. Fractionation of Pseudomonas aeruginosa mucus by diafiltration and biological properties of isolated fractions Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 50-55
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18
van Maarseveen, E.M.; Man, W.Hong.; Touw, D.J.; Bouma, A.W.; van Zanten, A.R.H. 2011: Continuous and intermittent infusion of vancomycin equally effective: review of the literature Nederlands Tijdschrift Voor Geneeskunde 155(42): A2667
Watanabe, Y.; Tsumura, H.; Sasaki, H.; Morimoto, T. 1990: The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers Clinical Therapeutics 12(6): 534-546
Knight, T.; Besa, E.C.; Joseph, R.R.; Baskin, S.I. 1983: Effect of intermittent and continuous administration of L-cysteine hydrochloride on L1210 mouse leukemia Cancer Treatment Reports 67(3): 319-320
Owens, R.C.; Ambrose, P.G.; Quintiliani, R. 1997: Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationale Connecticut Medicine 61(4): 225-227
Nomiya, B.; Kawaharajo, K.; Watanabe, T.; Tamura, S. 1972: Pseudomonas aeruginosa. I. Isolation of P. aeruginosa in nature and animals, with special reference to mice and guinea pigs Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 27(5): 641-648
Cristalli, A.; Taglione, G.C.; Prosperi, M.; Amici, O.; Mazza, E. 1995: Effectiveness and modality of continuous infusion administration of atracurium dibesylate Minerva Anestesiologica 61(3): 83-86
Treshchanina, N.A.; Nesmeianova, M.A.; Zhdan-Pushkina, S.M. 1981: Exogenous orthophosphate regulation of the phosphohydrolase activities of Pseudomonas aeruginosa and Pseudomonas maltophilia Mikrobiologiia 50(6): 996-1001
Cisterna Cancer, R. 1998: General characteristics of Pseudomonas and other related bacteria. Pathogenic ability of Pseudomonas aeruginosa Revista Clinica Espanola 198(Suppl 2): 3-9
De Leon-Casasola, O.A.; Lema, M.J.; Emrich, L.; Syed, N. 1991: Continuous 2-chloroprocaine infusion versus intermittent bolus injections of bupivacaine or 2-chloroprocaine for epidural anesthesia in cesarean delivery Regional Anesthesia 16(3): 154-160
Stanislavskiĭ, E.S.; Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Chekan, L.V. 1981: Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 37-40